Skip to main content

Induction of anti-pneumococcal cell wall polysaccharide antibodies by type 4 pneumococcal polysaccharide-protein conjugates

Abstract

We have prepared polysaccharide-protein conjugates consisting of type 4 pneumococcal capsular polysaccharide (PS4) coupled to tetanus toxoid. The PS4 preparation used contained 2.5% pneumococcal cell wall polysaccharide (CPs). During the conjugation process, in addition to PS4-protein conjugates, CPs-protein conjugates were also formed. After immunization with PS4-protein conjugates, CPs-protein conjugates that are present as a contaminant induce IgG anti-CPs antibodies in mice. Pneumococcal oligosaccharides, prepared by periodate oxidation of PS4, did not contain detectable amounts of CPs; hence, oligosaccharide-protein conjugates did not induce anti-CPs antibodies.

References

  1. Anderson P, Pichichero ME, Insel RA (1985) Immunogens consisting of oligosaccharides from the capsule of Haemophilus influenzae type b coupled to diphtheria toxoid or the toxin protein CRM 197. J Clin Invest 76:52–59

    Google Scholar 

  2. Barett DJ (1985) Human immune responses to polysaccharide antigens: an analysis of bacterial polysaccharide vaccines in infants. Adv Pediatr 32:139–158

    Google Scholar 

  3. Briles DE, Nahm M, Schroer K, Davie J, Baker P, Kearney J, Barletta R (1981) Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 Streptococcus pneumoniae. J Exp Med 153:694–705

    Google Scholar 

  4. Carlson AJ, Davidson WL, Mclean AA (1979) Pneumococcal vaccine: dose, revaccination and coadministration with influenza vaccine (40596). Proc Soc Exp Biol Med 161:558–563

    Google Scholar 

  5. Cowan MJ, Ammann AJ, Wara DW, Howie VM, Schultz L, Doyle N, Kaplan M (1978) Pneumococcal polysaccharide immunization in infants and children. Pediatrics 62:721–729

    Google Scholar 

  6. Douglas RM, Mules HB (1986) Vaccination against Streptococcus pneumoniae in childhood: lack of a demonstrable benefit in young Australian children. J Infect Dis 149:861–869

    Google Scholar 

  7. Fairchild RL, Sterner KE, Braley-Mullen H (1986) Primary murine immunoglobulin M responses to certain pneumococcal capsular polysaccharides consist primarily of antipneumococcal cell wall carbohydrate antibodies. Infect Immun 52:867–871

    Google Scholar 

  8. Gray DM, Dillon HC (1986) Clinical and epidemiologic studies of pneumococcal infection in children. Pediatr Infect Dis 5:201–207

    Google Scholar 

  9. Hammarström L, Persson MAA, Smith CIE (1985) Immunoglobulin subclass distribution of human anti carbohydrate antibodies: aberrant pattern in IgA deficient donors. Immunology 54:821–826

    Google Scholar 

  10. Holmberg H, Krook A, Sjogren AM (1985) Determination of antibodies to pneumococcal C polysaccharide in patients with community acquired pneumonia. J Clin Microbiol 22:808–814

    Google Scholar 

  11. Jennings HJ, Lugowski C, Young NM (1980) Structure of the complex polysaccharide C-substance from Streptococcus pneumoniae type 1. Biochemistry 19:4712–4719

    Google Scholar 

  12. Koskela M (1987) Serum antibodies to pneumococcal C polysaccharide in children: response to acute pneumococcal otitis media or to vaccination. Pediatr Infec Dis J 6:519–526

    Google Scholar 

  13. Milligan GN, Braley-Mullen H (1989) Production and characterization of monoclonal antibodies specific for types 6 and 19 pneumococcal polysaccharides. Mol Immunol 26:799–807

    Google Scholar 

  14. Milligan GN, Fairchild RL, Sterner KE, Braley-Mullen H (1990) Type 6 and 19 pneumococcal polysaccharides coupled to erythrocytes elicit pneumococcal cell wall-specific primary IgM responses and capsular polysaccharide-specific secondary IgG responses. Eur J Immunol 20:595–603

    Google Scholar 

  15. Mosier DE, Subbarao B (1982) Thymus-independent antigens: complexity of B lymphocyte activation revealed. Immunol Today 3:217–222

    Google Scholar 

  16. Musher DM, Watson DA, Baughn RE (1990) Does naturally acquired IgG antibody to cell wall polysaccharide protect human subjects against pneumococcal infection?. J Infect Dis 161:736–740

    Google Scholar 

  17. Musher DM, Luchi MJ, Watson DA, Hamilton R, Baughn RE (1990) Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide. J Infect Dis 161:728–735

    Google Scholar 

  18. Pedersen FK, Henrichsen J, Sørensen U, Nielsen JL (1982) Anti C-carbohydrate antibodies after pneumococcal vaccination. Acta Pathol Microbiol Scand [C] 90:353–355

    Google Scholar 

  19. Peeters CCAM, Tenbergen-Meekes AJ, Evenberg DE, Poolman JT, Zegers BJM, Rijkers GT (1991) A comparative study of the immunogenicity of pneumococcal type 4 polysaccharide and oligosaccharide tetanus toxoid conjugates in adult mice. J Immunol 146:4308–4314

    Google Scholar 

  20. Perlmutter RM, Hamsburg D, Briles DE, Nicoletti RA, Davie JM (1978) Subclass restriction of murine anti-carbohydrate antibodies. J Immunol 21:566–572

    Google Scholar 

  21. Robbins JB, Schneerson R (1990) Polysaccharide-protein conjugates: a new generation of vaccines. J Infect Dis 161:821–832

    Google Scholar 

  22. Rosen C, Christensen P, Hovelius B (1983) Effect of pneumococcal vaccination on upper respiratory tract infection in children: design of a follow-up study. J Infect Dis [Suppl] 39:39–44

    Google Scholar 

  23. Rynnel-Dagoö B, Freyd A, Hammarström L, Oxelius V, Persson MAA, Smith CIE (1986) Pneumococcal antibodies of different immunoglobulin subclasses in normal and IgG deficient individuals of various ages. Acta Otolaryngol 101:146–151

    Google Scholar 

  24. Sørensen UB, Henrichsen J (1984) C-polysaccharide in a pneumococcal vaccine. Acta Pathol Microbiol Immunol Scand [C] 92:351–356

    Google Scholar 

  25. Sørensen UB, Agger R, Bennedsen J, Henrichsen J (1984) Phosphorylocholine determinants in six pneumococccal capsular polysaccharides detected by monoclonal antibody. Infect Immun 43:876–878

    Google Scholar 

  26. Sørensen UB, Henrichsen J, Chen MC, Szu SC (1990) Covalent linkage between the capsular polysaccharide and the cell wall peptidoglycan of Streptococcus pneumoniae revealed by immunochemical methods. Microbiol Pathol 8:325–334

    Google Scholar 

  27. Szu SC, Clarke S, Robbins JB (1983) Protection against pneumococcal infection in mice conferred by phosphocholine-binding antibodies: specificity of the phosphocholine binding and relation to several types. Infect Immun 39:993–999

    Google Scholar 

  28. Szu SC, Schneerson R, Robbins JB (1986) Rabbit antibodies to the cell wall polysaccharide of Streptococcus pneumoniae fail to protect mice from lethal challenge with encapsulated pneumococci. Infect Immun 54:448–455

    Google Scholar 

  29. Wallick S, Clafin JL, Briles DE (1983) Resistance to Streptococcus pneumoniae is induced by a phosphocholine-protein conjugate. J Immunol 130:2871–2875

    Google Scholar 

Download references

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Peeters, C., Tenbergen-Meekes, AM., Poolmann, J. et al. Induction of anti-pneumococcal cell wall polysaccharide antibodies by type 4 pneumococcal polysaccharide-protein conjugates. Med Microbiol Immunol 181, 35–42 (1992). https://doi.org/10.1007/BF00193394

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00193394

Keywords

  • Cell Wall
  • Polysaccharide
  • Oligosaccharide
  • Tetanus
  • Periodate